Acute Ischemic Stroke in Nonconvulsive Status Epilepticus–Underestimated? Results from an Eight-Year Cohort Study

Article information

J Stroke. 2017;19(2):236-238

Publication date (electronic) : 2017 May 2

doi : https://doi.org/10.5853/jos.2016.01669

^aDepartment of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland

^bDepartment of Intensive Care Medicine, University Hospital Basel, Basel, Switzerland

Correspondence: Gian Marco De Marchis Department of Neurology and Stroke Center, University Hospital Basel, Petersgraben 4CH-4031 Basel, Switzerland Tel: +41-61-32 87302 Fax: +41-61-265 5544 E-mail: gian.demarchis@usb.ch

*Christopher Traenka and Gian Marco De Marchis contributed equally to the manuscript as first author.

Received 2016 October 27; Revised 2016 December 13; Accepted 2017 January 22.

Dear Sir:

Acute ischemic stroke (AIS) can be associated with status epilepticus (SE). Among 889 patients hospitalized for AIS and prospectively monitored with continuous electronecephalography (EEG)-monitoring, nonconvulsive SE (NCSE) was detected in 3.6% [1]. This finding suggests that AIS may cause NCSE and may prompt clinicians to look for AIS in patients hospitalized for SE of yet unknown etiology. However, the frequency of AIS among patients hospitalized for SE is unknown. In the present observational study, we assessed the frequency of AIS in a cohort of consecutive patients hospitalized in an intensive care unit (ICU) for EEG-confirmed SE.

From January 2005 to December 2012, all SE patients ≥18 years of age admitted to the ICUs of the University Hospital Basel, Switzerland, were consecutively enrolled in a prospective database. All patients underwent at least one EEG >30 minutes or continuous video EEG-monitoring, uncovering SE from different etiologies. SE was defined according to the current guidelines for the evaluation and management of SE [2,3]. Patients with SE following hypoxic encephalopathy were excluded from this study. We identified all patients who had AIS as confirmed by diffusion weighted and apparent diffusion coefficient magnetic resonance imaging (MRI) within ±7 days from onset of SE.

Of 333 consecutive patients with SE enrolled in the SE database, 275 patients were included in the present analysis, 58 patients with hypoxic encephalopathy were excluded. The distribution of different types of SE is shown in Table 1; four out of five patients had NCSE. Table 1 displays the proportion of presumed etiologies of SE within the cohort. An acute etiology according to the International League Against Epilepsy [4] was found in 124 patients (45%). Overall, of 275 patients with SE, 262 (95%) had any cerebral imaging (MRI, computed tomography [CT], or both) within ±7 days from SE onset. Brain MRI was performed in 128 SE patients (49%, 128 of 262), the remaining 134 patients had CT only.

Table 1.

Patient characteristics, demographics and distribution of Status epilepticus subtypes

Brain MRI identified AIS in nine patients, i.e. in 7% of all patients undergoing MRI and 3% of the whole cohort. AIS accounted for 7.2% of all patients with an acute etiology (according to the International League Against Epilepsy) [4] underlying SE. Chronic stroke was identified as underlying etiology of SE in 26 patients (9%). AIS involved both the cortex and white matter in all patients, with an ischemic pattern implying primary AIS rather than an ischemic injury secondary to sustained seizures. Among nine patients with AIS confirmed by brain MRI, three patients had no CT-signs of early or chronic brain ischemia. In patients with a CT negative for ischemia, MRI was performed within a median of six days (range 3-7 days) after the diagnosis of SE. All patients with AIS had NCSE, and other plausible etiologies of NCSE were not identified. Four AIS-patients (44% of AIS-patients) died after a median of 20 hospitalization days (interquartile range 12.3-48 days).

The three key findings of this study are: (1) a 7% AIS-frequency in patients hospitalized for SE undergoing MRI; (2) one third of patients with AIS were missed on cerebral CT; (3) the ischemic pattern on brain MRI and the lack of other NCSE-etiologies suggests that the AIS itself may have triggered NCSE.

Previous studies identified acute cerebrovascular disease in 8–22% of patients to be the underlying etiology of SE [5-7]. Although in line with these previous studies, the rather small number of AIS in our SE cohort might result from our strict criteria of close temporal association of AIS and SE (i.e. 7 days), a definition which is missing in the aforementioned studies.

Recently, Algethamy et al. [8] underscored the added value of brain MRI over cerebral CT in ICU-patients with neurological impairment. Among ICU-patients undergoing both a brain CT and MRI, in 95% “MRI revealed clinically relevant additional abnormalities over CT”. The added sensitivity of brain MRI over cerebral CT was greater in the detection of ischemic stroke and neoplastic lesions [8]. In another study on ICU-patients who underwent brain MRI for neurological impairment, AIS was uncovered in 40% (59/146), along with a high burden of white matter hyperintensities. Notably, patient transport from the ICUs to the MRI did not cause any adverse events or safety issues in these patients [9]. As a limitation, we are not able to provide a consistent correlation between AIS and EEG-findings.

As a limitation, we are not able to provide a consistent correlation between AIS and EEG-findings.

Identifying AIS should lead to prophylaxis for stroke recurrence, like in any other AIS-patient. Since the duration of NCSE is associated with worse functional and cognitive outcomes [10], every effort should be performed to treat not only NCSE itself, but also to find and treat its cause.

In summary, AIS is a rare, likely underdetected but relevant etiology of NCSE. Hence, if the cause of NCSE remains unclear, a negative cerebral CT should be rapidly followed by brain MRI.

Notes

The authors have no financial conflicts of interest.

References

1. Belcastro V, Vidale S, Gorgone G, Pisani LR, Sironi L, Arnaboldi M, et al. Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study. J Neurol 2014;261:2136–2142.

2. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3–23.

3. Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia 1999;40:120–122.

4. Guidelines for epidemiologic studies on epilepsy. Commission on epidemiology and prognosis, international league against epilepsy. Epilepsia 1993;34:592–596.

5. Sánchez S, Rincon F. Status epilepticus: epidemiology and public health needs. J Clin Med 2016;5:71.

6. Ozdilek B, Midi I, Agan K, Bingol CA. Episodes of status epilepticus in young adults: etiologic factors, subtypes, and outcomes. Epilepsy Behav 2013;27:351–354.

7. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029–1035.

8. Algethamy HM, Alzawahmah M, Young GB, Mirsattari SM. Added value of MRI over CT of the brain in intensive care unit patients. Can J Neurol Sci 2015;42:324–332.

9. Sutter R, Chalela JA, Leigh R, Kaplan PW, Yenokyan G, Sharshar T, et al. Significance of parenchymal brain damage in patients with critical illness. Neurocrit Care 2015;23:243–252.

10. De Marchis GM, Pugin D, Meyers E, Velasquez A, Suwatcharangkoon S, Park S, et al. Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome. Neurology 2016;86:253–260.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Table 1.

Patient characteristics, demographics and distribution of Status epilepticus subtypes

Variable	Value
(A) Clinical characteristics and distribution of SE subtypes among all included patients (n=275)^*
Presumed etiology of SE
AIS	9 (3)
Old stroke	26 (9)
Epilepsy	32 (12)
Brain tumor	30 (11)
Intracranial hemorrhage	26 (10)
Alcohol or drug withdrawal	18 (7)
Traumatic brain injury	16 (6)
Infectious encephalitis	16 (6)
Neurodegenerative disease	14 (5)
Post brain surgery	13 (4)
Acute metabolic derangement	12 (4)
Others	32 (12)
Unknown	31 (11)
Presumed etiology grouped according to the International League Against Epilepsy [4]
Acute etiology	124 (45)
Remote etiology	68 (25)
Progressive central nervous system disorders	23 (8)
Unprovoked/unknown etiology	60 (22)
SE types
NCSE in coma	87 (32)
Complex partial SE	113 (41)
Convulsive SE	58 (21)
Simple partial SE	13 (5)
Absence SE	4 (1)
(B) Demographics, baseline characteristics of patients with NCSE and AIS (n=9)^†
Age, median years (range)	75 (58–84)
Sex, female	5 (56)
Glucose, mmol/L, median (range)	7 (6–9.9)
Creatinine, mmol/L, median (range)	110 (43–428)
Modified Charlson Comorbidity Index, median (range)	2 (0–6)
History of prior ischemic stroke^‡	2 (22)
Lesion size on DWI-MRI)
Small: 1-10 cm³	4 (44)
Medium: 11-100 cm³	3 (33)
Large: >100 cm³	2 (22)
Cortical involvement	9 (100)

Values are presented as n (%) unless otherwise indicated.

SE, status epilepticus; AIS, acute ischemic strok; NSCE, nonconvulsive SE.

(A) Clinical characteristics and distribution of SE subtypes among all patients included in the study;

^†

(B) Baseline and neuroimaging characteristics of the nine patients with AIS in close temporal association to nonconvulsive SE (NCSE);

^‡

Prior ischemic stroke defined as: Prior acute focal neurological deficit(s) attributable to focal brain ischaemia, lasting >24 hours.